An Analysis of the Sequence Variability of Meningococcal fHbp, NadA and NHBA over a 50-Year Period in the Netherlands

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Bambini, Stefania ^a   Piet, Jurgen ^b   Muzzi, Alessandro ^a   Keijzers, Wendy ^b,c   Comandi, Sara ^a   De Tora, Lisa ^a   Pizza, Mariagrazia ^a   Rappuoli, Rino ^a   van de Beek, Diederik ^b   van der Ende, Arie ^b,c   Comanducci, Maurizio ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Netherlands Reference Laboratory for Bacterial Meningitis   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; FACTOR H BINDING PROTEIN; NEISSERIA ADHESIN A; NEISSERIAL HEPARIN BINDING ANTIGEN; UNCLASSIFIED DRUG; ADHESIN; BACTERIAL PROTEIN; FACTOR H-BINDING PROTEIN, NEISSERIA MENINGITIDIS; NADA PROTEIN, NEISSERIA MENINGITIDIS;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; FACTOR H BINDING PROTEIN GENE; GENE EXPRESSION REGULATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; INVASIVE SPECIES; MOLECULAR CLONING; MOLECULAR EVOLUTION; NEISSERIA ADHESIN A GENE; NEISSERIA MENINGITIDIS; NEISSERIAL HEPARIN BINDING ANTIGEN GENE; NETHERLANDS; SEQUENCE ANALYSIS; CHEMISTRY; CLASSIFICATION; GENETICS; IMMUNOLOGY; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; TIME;

ADHESINS, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; EVOLUTION, MOLECULAR; GENETIC VARIATION; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS, SEROGROUP B; NETHERLANDS; PHYLOGENY; TIME FACTORS;

EID: 84878152623     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065043     Document Type: Article

References (63)

1. Jolley KA, Wilson DJ, Kriz P, McVean G, Maiden MC, (2005) The influence of mutation, recombination, population history, and selection on patterns of genetic diversity in Neisseria meningitidis. Mol Biol Evol 22: 562-569.
2. Harrison OB, Evans NJ, Blair JM, Grimes HS, Tinsley CR, et al. (2009) Epidemiological evidence for the role of the hemoglobin receptor, hmbR, in meningococcal virulence. J Infect Dis 200: 94-98.
3. Caugant DA, Mocca LF, Frasch CE, Froholm LO, Zollinger WD, et al. (1987) Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J Bacteriol 169: 2781-2792.
4. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, et al. (1998) Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95: 3140-3145.
5. Maiden MC, (2006) Multilocus sequence typing of bacteria. Annu Rev Microbiol 60: 561-588.
6. Brehony C, Jolley KA, Maiden MC, (2007) Multilocus sequence typing for global surveillance of meningococcal disease. FEMS Microbiol Rev 31: 15-26.
7. Achtman M, editor (1995) Meningococcal disease. New York: Wiley. 159-175 p.
8. Callaghan MJ, Jolley KA, Maiden MC, (2006) Opacity-associated adhesin repertoire in hyperinvasive Neisseria meningitidis. Infect Immun 74: 5085-5094.
9. Yazdankhah SP, Kriz P, Tzanakaki G, Kremastinou J, Kalmusova J, et al. (2004) Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol 42: 5146-5153.
10. Law DK, Lorange M, Ringuette L, Dion R, Giguere M, et al. (2006) Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19). J Clin Microbiol 44: 2743-2749.
11. Budroni S, Siena E, Dunning Hotopp JC, Seib KL, Serruto D, et al. (2011) Neisseria meningitidis is structured in clades associated with restriction modification systems that modulate homologous recombination. Proc Natl Acad Sci U S A 108: 4494-4499.
12. Caugant DA, (2008) Genetics and evolution of Neisseria meningitidis: importance for the epidemiology of meningococcal disease. Infect Genet Evol 8: 558-565.
13. Buckee CO, Gupta S, Kriz P, Maiden MC, Jolley KA, (2010) Long-term evolution of antigen repertoires among carried meningococci. Proc Biol Sci 277: 1635-1641.
14. Buckee CO, Jolley KA, Recker M, Penman B, Kriz P, et al. (2008) Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis. Proc Natl Acad Sci U S A 105: 15082-15087.
15. Caugant DA, Maiden MC, (2009) Meningococcal carriage and disease--population biology and evolution. Vaccine 27Suppl 2: B64-70.
16. Jodar L, Feavers IM, Salisbury D, Granoff DM, (2002) Development of vaccines against meningococcal disease. Lancet 359: 1499-1508.
17. Van Der Ley P, Poolman JT, (1992) Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein. Infect Immun 60: 3156-3161.
18. Peeters CC, Rumke HC, Sundermann LC, Rouppe van der Voort EM, Meulenbelt J, et al. (1996) Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine 14: 1009-1015.
19. Cartwright K, Morris R, Rumke H, Fox A, Borrow R, et al. (1999) Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins. Vaccine 17: 2612-2619.
20. Rappuoli R, (2001) Reverse vaccinology, a genome-based approach to vaccine development. Vaccine 19: 2688-2691.
21. Tettelin H, Saunders NJ, Heidelberg J, Jeffries AC, Nelson KE, et al. (2000) Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287: 1809-1815.
22. Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, et al. (2000) Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287: 1816-1820.
23. Vogel U, Taha MK, Vazquez JA, Findlow J, Claus H,et al. (2013) Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis.
24. Kimura A, Toneatto D, Kleinschmidt A, Wang H, Dull P, (2011) Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningococcal isolates. Clin Vaccine Immunol 18: 483-486.
25. Bai X, Findlow J, Borrow R, (2011) Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles. Expert Opin Biol Ther 11: 969-985.
26. Sexton K, Lennon D, Oster P, Aaberge I, Martin D,et al. (2004) Proceedings of the Meningococcal Vaccine Strategy World Health Organization satellite meeting, 10 March 2004, Auckland, New Zealand. N Z Med J 117: 1 p preceding U1027.
27. Fletcher LD, Bernfield L, Barniak V, Farley JE, Howell A, et al. (2004) Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect Immun 72: 2088-2100.
28. Masignani V, Comanducci M, Giuliani MM, Bambini S, Adu-Bobie J, et al. (2003) Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J Exp Med 197: 789-799.
29. Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH, et al. (2006) The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol 177: 501-510.
30. Seib KL, Brunelli B, Brogioni B, Palumbo E, Bambini S, et al. (2011) Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies. Infect Immun 79: 970-981.
31. Plested JS, Welsch JA, Granoff DM, (2009) Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity. Clin Vaccine Immunol 16: 785-791.
32. Seib KL, Serruto D, Oriente F, Delany I, Adu-Bobie J, et al. (2009) Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37. Infect Immun 77: 292-299.
33. Welsch JA, Ram S, Koeberling O, Granoff DM, (2008) Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen. J Infect Dis 197: 1053-1061.
34. Brunelli B, Del Tordello E, Palumbo E, Biolchi A, Bambini S, et al. (2011) Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1. Vaccine 29: 1072-1081.
35. Murphy E, Andrew L, Lee KL, Dilts DA, Nunez L, et al. (2009) Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis. J Infect Dis 200: 379-389.
36. Marsh JW, Shutt KA, Pajon R, Tulenko MM, Liu S, et al. (2011) Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates. Vaccine 29: 6049-6058.
37. Serruto D, Spadafina T, Ciucchi L, Lewis LA, Ram S, et al. (2010) Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc Natl Acad Sci U S A 107: 3770-3775.
38. Bambini S, Muzzi A, Olcen P, Rappuoli R, Pizza M, et al. (2009) Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus. Vaccine 27: 2794-2803.
39. Jacobsson S, Hedberg ST, Molling P, Unemo M, Comanducci M, et al. (2009) Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease. Vaccine 27: 1579-1584.
40. Giuliani MM, Adu-Bobie J, Comanducci M, Arico B, Savino S, et al. (2006) A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci U S A 103: 10834-10839.
41. Welsch JA, Moe GR, Rossi R, Adu-Bobie J, Rappuoli R, et al. (2003) Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity. J Infect Dis 188: 1730-1740.
42. Capecchi B, Adu-Bobie J, Di Marcello F, Ciucchi L, Masignani V, et al. (2005) Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells. Mol Microbiol 55: 687-698.
43. Comanducci M, Bambini S, Brunelli B, Adu-Bobie J, Arico B, et al. (2002) NadA, a novel vaccine candidate of Neisseria meningitidis. J Exp Med 195: 1445-1454.
44. Comanducci M, Bambini S, Caugant DA, Mora M, Brunelli B, et al. (2004) NadA diversity and carriage in Neisseria meningitidis. Infect Immun 72: 4217-4223.
45. Lucidarme J, Comanducci M, Findlow J, Gray SJ, Kaczmarski EB, et al. (2009) Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales. J Clin Microbiol 47: 3577-3585.
46. Haubold B, Hudson RR, (2000) LIAN 3.0: detecting linkage disequilibrium in multilocus data. Linkage Analysis. Bioinformatics 16: 847-848.
47. Gupta S, Maiden MC, Feavers IM, Nee S, May RM, et al. (1996) The maintenance of strain structure in populations of recombining infectious agents. Nat Med 2: 437-442.
48. Van Looveren M, Vandamme P, Hauchecorne M, Wijdooghe M, Carion F, et al. (1998) Molecular epidemiology of recent belgian isolates of Neisseria meningitidis serogroup B. J Clin Microbiol 36: 2828-2834.
49. Martin DR, Walker SJ, Baker MG, Lennon DR, (1998) New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4. J Infect Dis 177: 497-500.
50. Elias J, Schouls LM, van de Pol I, Keijzers WC, Martin DR, et al. (2010) Vaccine preventability of meningococcal clone, Greater Aachen Region, Germany. Emerg Infect Dis 16: 465-472.
51. Anne Whitney LM, Mothershed E, Sacchi C, Schmink S, Theodore J,et al. (2006) Distribution of multi-locus sequence types of N. meningitidis serogroup B in the US, 2000-2005. Fifteenth International Pathogenic Conference 2006. Cairns, North Queensland, Australia.
52. Bart A, Dankert J, van der Ende A, (2000) Representational difference analysis of Neisseria meningitidis identifies sequences that are specific for the hyper-virulent lineage III clone. FEMS Microbiol Lett 188: 111-114.
53. Seib KL, Oriente F, Adu-Bobie J, Montanari P, Ferlicca F, et al. (2010) Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection. Vaccine 28: 2416-2427.
54. Dunphy KY, Beernink PT, Brogioni B, Granoff DM, (2011) Effect of factor H-binding protein sequence variation on factor H binding and survival of Neisseria meningitidis in human blood. Infect Immun 79: 353-359.
55. Echenique-Rivera H, Muzzi A, Del Tordello E, Seib KL, Francois P, et al. (2011) Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival. PLoS Pathog 7: e1002027.
56. Donnelly J, Medini D, Boccadifuoco G, Biolchi A, Ward J, et al. (2010) Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines. Proc Natl Acad Sci U S A 107: 19490-19495.
57. Didelot X, Maiden MC, (2010) Impact of recombination on bacterial evolution. Trends Microbiol 18: 315-322.
58. Jolley KA, Chan MS, Maiden MC, (2004) mlstdbNet- distributed multi-locus sequence typing (MLST) databases. BMC Bioinformatics 5: 86.
59. Heckenberg SG, de Gans J, Brouwer MC, Weisfelt M, Piet JR, et al. (2008) Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine (Baltimore) 87: 185-192.
60. Tamura K, Dudley J, Nei M, Kumar S, (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
61. Waterhouse AM, Procter JB, Martin DM, Clamp M, Barton GJ, (2009) Jalview Version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 25: 1189-1191.
62. Francisco AP, Bugalho M, Ramirez M, Carrico JA, (2009) Global optimal eBURST analysis of multilocus typing data using a graphic matroid approach. BMC Bioinformatics 10: 152.
63. Cramér H, editor (1946) Mathematical Methods of Statistics. p282 p.